GlassScriptPhysician profile
Tyler Clark
NPI 1831453778
$2,102.80
in general payments reported to CMS, 2019-2025
11 companies · $79.97 in 2025
The $79.97 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,472 · 2020: $151 · 2021: $137 · 2022: $61.02 · 2023: $131 · 2024: $70.46 · 2025: $79.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,627.78 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $90.44 | 2019-2023 | Xiaflex |
| Globus Medical, INC. | $88.65 | 2022-2025 | Distal Radius II, Autobahn, Anthem |
| Acumed LLC | $53.00 | 2019 | |
| Bioventus LLC | $52.11 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Endo USA, INC. | $49.07 | 2024-2025 | Xiaflex |
| Smith+Nephew, INC. | $41.62 | 2023 | Stravix |
| Evolution Surgical, INC | $33.36 | 2023 | |
| Glaxosmithkline, LLC. | $30.04 | 2024 | Bexsero |
| Team_makena_llc | $20.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $16.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.